88 related articles for article (PubMed ID: 17488299)
1. Early apoptosis of blood monocytes is a determinant of survival in experimental sepsis by multi-drug-resistant Pseudomonas aeruginosa.
Antonopoulou A; Raftogiannis M; Giamarellos-Bourboulis EJ; Koutoukas P; Sabracos L; Mouktaroudi M; Adamis T; Tzepi I; Giamarellou H; Douzinas EE
Clin Exp Immunol; 2007 Jul; 149(1):103-8. PubMed ID: 17488299
[TBL] [Abstract][Full Text] [Related]
2. Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Antonopoulou A; Raftogiannis M; Koutoukas P; Tsaganos T; Tziortzioti V; Panagou C; Adamis T; Giamarellou H
BMC Infect Dis; 2006 Feb; 6():31. PubMed ID: 16504031
[TBL] [Abstract][Full Text] [Related]
3. Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniae.
Giamarellos-Bourboulis EJ; Tziortzioti V; Koutoukas P; Baziaka F; Raftogiannis M; Antonopoulou A; Adamis T; Sabracos L; Giamarellou H
J Antimicrob Chemother; 2006 May; 57(5):937-44. PubMed ID: 16549515
[TBL] [Abstract][Full Text] [Related]
4. The significance of oxidant/antioxidant balance for the pathogenesis of experimental sepsis by multidrug-resistant Pseudomonas aeruginosa.
Koussoulas V; Giamarellos-Bourboulis EJ; Adamis T; Mouktaroudi M; Sabracos L; Perrea D; Giamarellou H; Dionyssiou-Asteriou A
Prostaglandins Leukot Essent Fatty Acids; 2005 Jan; 72(1):41-7. PubMed ID: 15589398
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-2 enhances survival in experimental sepsis induced by multidrug-resistant Pseudomonas aeruginosa.
Tzepi IM; Giamarellos-Bourboulis EJ; Carrer DP; Tsaganos T; Claus RA; Vaki I; Pelekanou A; Kotsaki A; Tziortzioti V; Topouzis S; Bauer M; Papapetropoulos A
J Pharmacol Exp Ther; 2012 Nov; 343(2):278-87. PubMed ID: 22859861
[TBL] [Abstract][Full Text] [Related]
6. Early apoptosis of monocytes contributes to the pathogenesis of systemic inflammatory response and of bacterial translocation in an experimental model of multiple trauma.
Efstathopoulos N; Tsaganos T; Giamarellos-Bourboulis EJ; Kaldis P; Nicolaou V; Papalois A; Koutoukas P; Papachristou G; Giamarellou H
Clin Exp Immunol; 2006 Jul; 145(1):139-46. PubMed ID: 16792684
[TBL] [Abstract][Full Text] [Related]
7. n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Mouktaroudi M; Adamis T; Koussoulas V; Baziaka F; Perrea D; Karayannacos PE; Giamarellou H
Antimicrob Agents Chemother; 2004 Dec; 48(12):4713-7. PubMed ID: 15561848
[TBL] [Abstract][Full Text] [Related]
8. Oleuropein: a novel immunomodulator conferring prolonged survival in experimental sepsis by Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Geladopoulos T; Chrisofos M; Koutoukas P; Vassiliadis J; Alexandrou I; Tsaganos T; Sabracos L; Karagianni V; Pelekanou E; Tzepi I; Kranidioti H; Koussoulas V; Giamarellou H
Shock; 2006 Oct; 26(4):410-6. PubMed ID: 16980890
[TBL] [Abstract][Full Text] [Related]
9. Impact of multidrug resistance on experimental empyema by Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Tzepi I; Tsovolou I; Spyridaki A; Tsaganos T; Vaki I; Kotsaki A; Polychronopoulos V
Respiration; 2011; 82(1):46-53. PubMed ID: 21525725
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Adamis T; Laoutaris G; Sabracos L; Koussoulas V; Mouktaroudi M; Perrea D; Karayannacos PE; Giamarellou H
Antimicrob Agents Chemother; 2004 Jan; 48(1):93-9. PubMed ID: 14693524
[TBL] [Abstract][Full Text] [Related]
11. Experimental sepsis using Pseudomonas aeruginosa: the significance of multi-drug resistance.
Giamarellos-Bourboulis EJ; Koussoulas V; Panagou C; Adamis T; Baziaka F; Skiadas I; Perrea D; Dionyssiou-Asteriou A; Giamarellou H
Int J Antimicrob Agents; 2004 Oct; 24(4):357-61. PubMed ID: 15380261
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effect of three-day continuous administration of clarithromycin for experimental sepsis due to multidrug-resistant Pseudomonas aeruginosa.
Baziaka F; Giamarellos-Bourboulis EJ; Raftogiannis M; Adamis T; Tziortzioti V; Sabracos L; Chrisofos M; Koutoukas P; Giamarellou H; Douzinas EE
J Chemother; 2008 Feb; 20(1):63-8. PubMed ID: 18343746
[TBL] [Abstract][Full Text] [Related]
13. The impact of multidrug resistance on the pathogenicity of Escherichia coli: an experimental study.
Bristianou M; Panagou C; Adamis T; Raftogiannis M; Antonopoulou A; Chrisofos M; Galani I; Kanellakopoulou K; Tsaganos T; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2008 Mar; 31(3):216-23. PubMed ID: 18248963
[TBL] [Abstract][Full Text] [Related]
14. Early cutaneous alterations in experimental sepsis by Pseudomonas aeruginosa.
Petropoulou H; Giamarellos-Bourboulis EJ; Kavatzas N; Stratigos A; Mouktaroudi M; Adamis T; Baziaka F; Katsambas AD; Stavrianeas NG
Dermatology; 2004; 209(2):111-6. PubMed ID: 15316164
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory intervention in sepsis by multidrug-resistant Pseudomonas aeruginosa with thalidomide: an experimental study.
Giamarellos-Bourboulis EJ; Bolanos N; Laoutaris G; Papadakis V; Koussoulas V; Perrea D; Karayannacos PE; Giamarellou H
BMC Infect Dis; 2005 Jun; 5():51. PubMed ID: 15978135
[TBL] [Abstract][Full Text] [Related]
16. Esmolol: immunomodulator in pyelonephritis by Pseudomonas aeruginosa.
Dimopoulos G; Theodorakopoulou M; Armaganidis A; Tzepi IM; Lignos M; Giamarellos-Bourboulis EJ; Tsaganos T
J Surg Res; 2015 Sep; 198(1):175-84. PubMed ID: 26073350
[TBL] [Abstract][Full Text] [Related]
17. [The effect of caspase-3 inhibitor on the concentrations of serum inflammatory cytokines in sepsis related acute kidney injury induced by peritoneal cavity infection in mice].
Liu LX; Hu ZJ; Li Y; Su J; Huo Y; Fan LQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Dec; 22(12):736-9. PubMed ID: 21190601
[TBL] [Abstract][Full Text] [Related]
18. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.
Cirioni O; Giacometti A; Ghiselli R; Orlando F; Kamysz W; D'Amato G; Mocchegiani F; Lukasiak J; Silvestri C; Saba V; Scalise G
J Infect Dis; 2004 Jul; 190(2):356-64. PubMed ID: 15216473
[TBL] [Abstract][Full Text] [Related]
19. Effect of clarithromycin in experimental empyema by multidrug-resistant Pseudomonas aeruginosa.
Tsovolou EC; Tzepi IM; Spyridaki A; Tsaganos T; Karagianni V; Menenakos E; Liakou P; Sabracos L; Zografos G; Giamarellos-Bourboulis EJ
APMIS; 2014 Jan; 122(1):68-75. PubMed ID: 23656439
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients.
Ploder M; Pelinka L; Schmuckenschlager C; Wessner B; Ankersmit HJ; Fuerst W; Redl H; Roth E; Spittler A
Shock; 2006 Feb; 25(2):129-34. PubMed ID: 16525350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
